Sean E Connolly - Immunology and Fibrosis/Global Drug Development, Bristol Myers Squibb

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 120 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Predicting Abatacept Retention Using Machine Learning

Rieke Alten,Claire Behar,Pierre Merckaert, Ebenezer Afari, Virginie Vannier-Moreau, Anael Ohayon,Sean E. Connolly, Aurélie Najm, Pierre-Antoine Juge, Gengyuan Liu,Angshu Rai,Yedid Elbez,Karissa Lozenski

Arthritis Research & Therapyno. 1 (2025): 1-11

Cited0Views0WOSBibtex

Sustained Remission and Outcomes with Abatacept Plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

Paul Emery,Yoshiya Tanaka,Vivian P. Bykerk,Thomas W. J. Huizinga,Gustavo Citera,Clifton O. Bingham,Subhashis Banerjee,Benjamin P. Soule,Marleen Nys,Sean E. Connolly,Karissa L. Lozenski,Joe Zhuo,Robert Wong,Kuan-Hsiang Gary Huang,Roy Fleischmann

Rheumatology and Therapy（2023）

Cited4Views0WOSBibtex

Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis in Routine Clinical Practice in Germany, Austria, and Switzerland: 2-Year Retention and Efficacy by Treatment Line and Serostatus

Rieke Alten,Hans-Peter Tony,Bettina Bannert,Hubert Nüßlein,Christiane Rauch,Sean E. Connolly,Melanie Chartier,Karissa Lozenski, Roland Hackl,Adrian Forster,Peter Peichl

CLINICAL RHEUMATOLOGY（2023）

Cited2Views0WOSBibtex

Baseline IL-10 Levels As a Predictive Biomarker for Achieving Clinical Response with Abatacept in ACPA Plus Patients with Early RA

Jinqi Liu,Yicong Li, Kai Fu,Chun Wu,Peter Schafer,Sean Connolly,Ian M. Catlett,Michael Maldonado,Robert Wong,Paul Emery,Yoshiya Tanaka,Vivian Bykerk,Clifton Bingham,Thomas Huizinga,Roy Fleischmann

ARTHRITIS & RHEUMATOLOGY (2023): 5042-5045

Cited0Views0Bibtex

Abatacept Modulates Both Global and Citrulline Specific T Cell Signatures: Results from Inhibition of Co-Simulation in Rheumatoid Arthritis Phase IV Trial

ARTHRITIS & RHEUMATOLOGY (2023): 2585-2586

Cited0Views0Bibtex

The Trajectory of Clinical Responses in Patients with Early Rheumatoid Arthritis Who Achieve Sustained Remission in Response to Abatacept: Subanalysis of AVERT-2, a Randomized Phase IIIb Study

Paul Emery,Yoshiya Tanaka,Vivian P. Bykerk,Clifton O. Bingham,Thomas W. J. Huizinga,Gustavo Citera,Kuan-Hsiang Gary Huang,Chun Wu,Sean E. Connolly,Yedid Elbez,Robert Wong,Karissa Lozenski,Roy Fleischmann

ARTHRITIS RESEARCH & THERAPY（2023）

Cited1Views0WOSBibtex

Reduction in Structural Damage Progression and Improvement in Clinical Response with Abatacept Treatment in Patients with ACPA plus , Early RA: Results from a Post Hoc Analysis of the AVERT-2 Study by Baseline Erosion Scores

Chahin Pachai,Sean E. Connolly,Yoshiya Tanaka,Vivian Bykerk,Tom Huizinga,Gustavo Citera,Clifton O. Bingham,Shuyan Du,Godehard Hoexter,Roy Fleischmann,Subhashis Banerjee,Paul Emery

ARTHRITIS & RHEUMATOLOGY（2022）

Cited0Views0Bibtex

Concordance of efficacy data collected in a clinical trial setting versus a registry study setting: Example of use of real-world data to support drug regulatory approval of abatacept for acute graft versus host disease prophylaxis

Christopher Bond,Tzuyung Douglas Kou,Leslie Kean,Linda J. Burns,Karissa Lozenski,Roxanne Kapikian,Xiao-Ying Tang,Mei-Jie Zhang,Michael Hemmer,Sean Connolly,Martin Polinsky,Brian Gavin,Andres Gomez,Marcelo Pasquini

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2022）

Cited0Views0Bibtex

Erosion Score and Erosive Joint Number Using Radiography: Clinical Implications in Patients with ACPA plus Early RA Treated with Abatacept

Chahin Pachai,Sean E. Connolly,Yoshiya Tanaka,Vivian Bykerk,Tom Huizinga,Gustavo Citera,Clifton O. Bingham,Shuyan Du,Godehard Hoexter,Paul Emery,Subhashis Banerjee,Roy Fleischmann

ARTHRITIS & RHEUMATOLOGY（2022）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn